| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Salomon Azoulay | Med | 2026-08-04 | 370 | $65.77 | $24.33kSell |
| Salomon Azoulay | Chief Medical Officer | 2026-05-08 | 55,000 | $10.46 | $575.30kBuy |
| Salomon Azoulay | Chief Medical Officer | 2026-05-08 | 55,000 | $38.38 | $2.11MSell |
| Salomon Azoulay | Chief Medical Officer | 2026-05-08 | 15,003 | $16.00 | $240.05kBuy |
| Salomon Azoulay | Chief Medical Officer | 2026-05-08 | 15,003 | $38.30 | $574.61kSell |
| P. Kent Hawryluk | President CEO | 2026-05-06 | 607 | $29.54 | $17.93kSell |
| Salomon Azoulay | Chief Medical Officer | 2026-05-06 | 231 | $29.54 | $6.82kSell |
| P. Kent Hawryluk | President CEO | 2026-03-13 | 18,500 | $28.41 | $525.66kBuy |
| P. Kent Hawryluk | President CEO | 2026-02-26 | 28,768 | $16.00 | $460.29kBuy |
| P. Kent Hawryluk | President CEO | 2025-10-24 | 182,859 | $3.25 | $594.29kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick J. Heron | 10.84% | 5,219,440 | $333.47M | Insider |
| Carl L. Gordon | 9.47% | 4,560,102 | $291.34M | Insider |
| Orbimed Advisors LLC | 9.47% | 4,560,102 | $291.34M | Insider |
| Frazier Life Sciences X LP | 9.45% | 4,552,774 | $290.88M | Insider |
| Ali Behbahani | 7.51% | 3,614,486 | $230.93M | Insider |
| Carmen Chang | 7.51% | 3,614,486 | $230.93M | Insider |
| Paul Edward Walker | 7.51% | 3,614,486 | $230.93M | Insider |
| Anthony A. Florence Jr. | 7.51% | 3,614,486 | $230.93M | Insider |
| Scott D. Sandell | 7.51% | 3,614,486 | $230.93M | Insider |
| Forest Baskett | 7.51% | 3,614,486 | $230.93M | Insider |